<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Furiex Pharmaceuticals</title>
	<atom:link href="http://www.furiex.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.furiex.com</link>
	<description>Expert. Focused. Fast.</description>
	<lastBuildDate>Tue, 31 Jan 2012 21:12:16 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=644254</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=644254#comments</comments>
		<pubDate>Tue, 31 Jan 2012 21:12:16 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=2011</guid>
		<description><![CDATA[

Related posts:Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome ...
Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting ...
Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2 ...

Related posts brought to you by Yet Another Related Posts [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=603486' rel='bookmark' title='Permanent Link: Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome'>Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745' rel='bookmark' title='Permanent Link: Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting'>Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2'>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome ...
Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting ...
Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2 ...

Related posts brought to you by Yet Another Related Posts [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=603486' rel='bookmark' title='Permanent Link: Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome'>Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745' rel='bookmark' title='Permanent Link: Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting'>Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2'>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=644254/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=641624</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=641624#comments</comments>
		<pubDate>Mon, 23 Jan 2012 21:14:14 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=2009</guid>
		<description><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=589174' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=561712' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=589174' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=561712' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=641624/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Announces Results for Phase II Trial of PPD-10558</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=631793</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=631793#comments</comments>
		<pubDate>Thu, 08 Dec 2011 22:06:42 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1993</guid>
		<description><![CDATA[

Related posts:Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome ...
Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting ...
Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2 ...

Related posts brought to you by Yet Another Related Posts [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=603486' rel='bookmark' title='Permanent Link: Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome'>Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745' rel='bookmark' title='Permanent Link: Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting'>Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2'>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome ...
Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting ...
Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2 ...

Related posts brought to you by Yet Another Related Posts [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=603486' rel='bookmark' title='Permanent Link: Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome'>Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745' rel='bookmark' title='Permanent Link: Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting'>Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2'>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=631793/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Confirms Takeda’s Submission of Alogliptin/Metformin Fixed Dose Combination NDA to the U.S. Food and Drug Administration</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=626429</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=626429#comments</comments>
		<pubDate>Wed, 23 Nov 2011 22:34:59 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1987</guid>
		<description><![CDATA[

Related posts:Furiex Confirms Takeda&#8217;s Resubmissions of Alogliptin NDAs to the U.S. Food and Drug Administration ...
Furiex Confirms Takeda Launches LIOVEL® LD and LIOVEL® HD, a Fixed Dose Combination of NESINA® and ACTOS®, for Type 2 Diabetes in Japan ...
Furiex Confirms Takeda Receives Approval of Additional NESINA® Combination Therapies with Sulfonylurea and Biguanide for Type 2 [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=593818' rel='bookmark' title='Permanent Link: Furiex Confirms Takeda&#8217;s Resubmissions of Alogliptin NDAs to the U.S. Food and Drug Administration'>Furiex Confirms Takeda&#8217;s Resubmissions of Alogliptin NDAs to the U.S. Food and Drug Administration</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=606670' rel='bookmark' title='Permanent Link: Furiex Confirms Takeda Launches LIOVEL® LD and LIOVEL® HD, a Fixed Dose Combination of NESINA® and ACTOS®, for Type 2 Diabetes in Japan'>Furiex Confirms Takeda Launches LIOVEL® LD and LIOVEL® HD, a Fixed Dose Combination of NESINA® and ACTOS®, for Type 2 Diabetes in Japan</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=552848' rel='bookmark' title='Permanent Link: Furiex Confirms Takeda Receives Approval of Additional NESINA<sup>®</sup> Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan'>Furiex Confirms Takeda Receives Approval of Additional NESINA<sup>®</sup> Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Confirms Takeda&#8217;s Resubmissions of Alogliptin NDAs to the U.S. Food and Drug Administration ...
Furiex Confirms Takeda Launches LIOVEL® LD and LIOVEL® HD, a Fixed Dose Combination of NESINA® and ACTOS®, for Type 2 Diabetes in Japan ...
Furiex Confirms Takeda Receives Approval of Additional NESINA® Combination Therapies with Sulfonylurea and Biguanide for Type 2 [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=593818' rel='bookmark' title='Permanent Link: Furiex Confirms Takeda&#8217;s Resubmissions of Alogliptin NDAs to the U.S. Food and Drug Administration'>Furiex Confirms Takeda&#8217;s Resubmissions of Alogliptin NDAs to the U.S. Food and Drug Administration</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=606670' rel='bookmark' title='Permanent Link: Furiex Confirms Takeda Launches LIOVEL® LD and LIOVEL® HD, a Fixed Dose Combination of NESINA® and ACTOS®, for Type 2 Diabetes in Japan'>Furiex Confirms Takeda Launches LIOVEL® LD and LIOVEL® HD, a Fixed Dose Combination of NESINA® and ACTOS®, for Type 2 Diabetes in Japan</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=552848' rel='bookmark' title='Permanent Link: Furiex Confirms Takeda Receives Approval of Additional NESINA<sup>®</sup> Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan'>Furiex Confirms Takeda Receives Approval of Additional NESINA<sup>®</sup> Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=626429/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call</title>
		<link>http://investor.furiex.com/eventdetail.cfm?eventid=105127</link>
		<comments>http://investor.furiex.com/eventdetail.cfm?eventid=105127#comments</comments>
		<pubDate>Wed, 02 Nov 2011 11:23:09 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1978</guid>
		<description><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=589174' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=561712' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=589174' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=561712' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/eventdetail.cfm?eventid=105127/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Reports Third Quarter 2011 Financial Results</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619748</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619748#comments</comments>
		<pubDate>Tue, 01 Nov 2011 21:12:16 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1976</guid>
		<description><![CDATA[

Related posts:Furiex Reports Second Quarter 2011 Financial Results ...
Furiex Reports First Quarter 2011 Financial Results.  Sign up to listen. ...
Furiex Reports Fourth Quarter 2010 Financial Results ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=596423' rel='bookmark' title='Permanent Link: Furiex Reports Second Quarter 2011 Financial Results'>Furiex Reports Second Quarter 2011 Financial Results</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=572944' rel='bookmark' title='Permanent Link: Furiex Reports First Quarter 2011 Financial Results.  <a href="http://investor.furiex.com/eventdetail.cfm?eventid=95047" >Sign up</a> to listen.'>Furiex Reports First Quarter 2011 Financial Results.  <a href="http://investor.furiex.com/eventdetail.cfm?eventid=95047" >Sign up</a> to listen.</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=551466' rel='bookmark' title='Permanent Link: Furiex Reports Fourth Quarter 2010 Financial Results'>Furiex Reports Fourth Quarter 2010 Financial Results</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Reports Second Quarter 2011 Financial Results ...
Furiex Reports First Quarter 2011 Financial Results.  Sign up to listen. ...
Furiex Reports Fourth Quarter 2010 Financial Results ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=596423' rel='bookmark' title='Permanent Link: Furiex Reports Second Quarter 2011 Financial Results'>Furiex Reports Second Quarter 2011 Financial Results</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=572944' rel='bookmark' title='Permanent Link: Furiex Reports First Quarter 2011 Financial Results.  <a href="http://investor.furiex.com/eventdetail.cfm?eventid=95047" >Sign up</a> to listen.'>Furiex Reports First Quarter 2011 Financial Results.  <a href="http://investor.furiex.com/eventdetail.cfm?eventid=95047" >Sign up</a> to listen.</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=551466' rel='bookmark' title='Permanent Link: Furiex Reports Fourth Quarter 2010 Financial Results'>Furiex Reports Fourth Quarter 2010 Financial Results</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619748/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745#comments</comments>
		<pubDate>Tue, 01 Nov 2011 20:40:22 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1973</guid>
		<description><![CDATA[

Related posts:Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome ...
Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone) ...
Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries ...

Related posts brought to [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=603486' rel='bookmark' title='Permanent Link: Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome'>Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=570031' rel='bookmark' title='Permanent Link: Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone)'>Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone)</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=644254' rel='bookmark' title='Permanent Link: Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries'>Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome ...
Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone) ...
Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries ...

Related posts brought to [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=603486' rel='bookmark' title='Permanent Link: Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome'>Furiex Reports Positive Phase II Results for MuDelta in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=570031' rel='bookmark' title='Permanent Link: Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone)'>Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone)</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=644254' rel='bookmark' title='Permanent Link: Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries'>Furiex Announces that the European Commission Endorses Positive Opinion of Priligy™ for the On-Demand Treatment of Premature Ejaculation in all European Union Countries</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619745/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619277</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619277#comments</comments>
		<pubDate>Mon, 31 Oct 2011 15:33:42 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1970</guid>
		<description><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2 ...
Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011 ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2'>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/eventdetail.cfm?eventid=105127' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=602534' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011'>Furiex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2 ...
Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011 ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2'>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/eventdetail.cfm?eventid=105127' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=602534' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011'>Furiex Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=619277/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Pharmaceuticals Announces Scientific Publications for JNJ-Q2</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690#comments</comments>
		<pubDate>Tue, 11 Oct 2011 16:26:31 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1957</guid>
		<description><![CDATA[

Related posts:Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting ...
Furiex Pharmaceuticals, Inc. Announces Presentation at the BIO CEO &#038; Investor Conference on February 15, 2011 ...
Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=619277' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting'>Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=548519' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals, Inc. Announces Presentation at the BIO CEO &#038; Investor Conference on February 15, 2011'>Furiex Pharmaceuticals, Inc. Announces Presentation at the BIO CEO &#038; Investor Conference on February 15, 2011</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting ...
Furiex Pharmaceuticals, Inc. Announces Presentation at the BIO CEO &#038; Investor Conference on February 15, 2011 ...
Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts [...]


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=619277' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting'>Furiex Pharmaceuticals Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=548519' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals, Inc. Announces Presentation at the BIO CEO &#038; Investor Conference on February 15, 2011'>Furiex Pharmaceuticals, Inc. Announces Presentation at the BIO CEO &#038; Investor Conference on February 15, 2011</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=613690/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Furiex Pharmaceuticals Announces Third Quarter 2011 Earnings Release and Conference Call</title>
		<link>http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502</link>
		<comments>http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502#comments</comments>
		<pubDate>Wed, 05 Oct 2011 21:11:05 +0000</pubDate>
		<dc:creator>Furiex</dc:creator>
				<category><![CDATA[Furiex News]]></category>

		<guid isPermaLink="false">http://www.furiex.com/?p=1945</guid>
		<description><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=589174' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=561712' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=641624' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></description>
			<content:encoded><![CDATA[

Related posts:Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call ...
Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call ...

Related posts brought to you by Yet Another Related Posts Plugin.


Related posts:<ol><li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=589174' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=561712' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call</a> <small>...</small></li>
<li><a href='http://investor.furiex.com/releasedetail.cfm?ReleaseID=641624' rel='bookmark' title='Permanent Link: Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call'>Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Earnings Release and Conference Call</a> <small>...</small></li>
</ol>

Related posts brought to you by <a href='http://mitcho.com/code/yarpp/'>Yet Another Related Posts Plugin</a>.]]></content:encoded>
			<wfw:commentRss>http://investor.furiex.com/releasedetail.cfm?ReleaseID=611502/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic page generated in 2.710 seconds. -->
<!-- Cached page generated by WP-Super-Cache on 2012-02-07 04:40:54 -->

